Artesunate versus quinine for treating severe malaria (Q24242928)

3

0 references

author name string

Katharine L Jones

1

1 reference

Sarah Donegan

2

1 reference

David G Lalloo

3

1 reference

publication date

17 October 2007

0 references

2007

1 reference

https://archive.lstmed.ac.uk/3028/1/Artesunate_versus_quinine_for_treating_severe_malaria.pdf

official website

1 reference

Cochrane Database of Systematic Reviews

published in

0 references

unknown value

object named as

Cochrane Database Of Systematic Reviews

1 reference

Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Randomized control trial of quinine and artesunate in complicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Pharmacokinetics and bioavailability of oral and intramuscular artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

High first dose quinine regimen for treating severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Artemisinin derivatives for treating severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Assessment of the neurotoxicity of oral dihydroartemisinin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Severe Hypoglycemia and Hyperinsulinemia in Falciparum Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Epidemiology of drug-resistant malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

Fatal neurotoxicity of arteether and artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

7 January 2021

Predictors of a fatal outcome following childhood cerebral malaria.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

7 January 2021

Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

7 January 2021

Studies of the neurotoxicity of oral artemisinin derivatives in mice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005967.PUB2

7 January 2021